CWB-20145

N/A

Report date: 2023/09/01 14:44:12
NME

Base Information

Drug NameCWB-20145
Drug Alias NameCWB-20145
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin, Milwaukee
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wisconsin, Milwaukee
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A